Translational Genomics Research Institute Foundation

Analysis

Translational Genomics Research Institute Foundation is a registered charity in United States, based in Phoenix, AZ. It received its IRS tax-exemption ruling in September 2004, 22 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending September 2023, Translational Genomics Research Institute Foundation reported income of $15.4m and spending of $17.0m, spending 110% of what it took in. Across the 5 years on record, from September 2019 to September 2023, income grew from $9.1m to $15.4m (+69%), an average of +14% a year. The sharpest change came in the year to September 2022, when income rose by 207%. Over the whole period it spent 106% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Translational Genomics Research Institute Foundation sits at the 87th percentile: it is larger than about 87% of them. Against every charity in United States with reported income it ranks in the 96th percentile, and in the 96th percentile within AZ. Charities of a similar size with the same main cause include Better Community Living Inc ($15.4m), Winifred Masterson Burke Medical Research ($15.4m) and Kershawhealth ($15.3m).

On its Form 990 for the period ending September 2023, revenue came from contributions and grants 94% of the total. Compensation of current officers, directors and key employees was $320k (1.9% of expenses). Other salaries and wages came to $998k. At year end it held assets of $22.6m against liabilities of $10.0m, net assets of $12.6m.

Data notes from the register: Spending has exceeded income in each of the last three reported years, so the charity has been drawing on reserves or other funds.